Stay updated on Itolizumab in Lupus Nephritis Clinical Trial

Sign up to get notified when there's something new on the Itolizumab in Lupus Nephritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Itolizumab in Lupus Nephritis Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A new Revision: v3.6.5 entry was added to the study history and the prior Revision: v3.6.4 entry was removed, indicating an update to the page's rendering/versioning rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-08-08T23:26:53.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 is added to the study history, while the previous entry v3.6.3 is removed. This reflects an update to the record's revision metadata.
    Difference
    0.1%
    Check dated 2026-07-25T12:46:52.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    A new page revision (v3.6.3) was added to the Study Record History and the previous revision (v3.6.2) was removed, reflecting a small update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-03T23:47:51.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.6.2) to the study's record history and removed the previous entry (v3.6.0). This indicates a minor page release update rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-06-26T20:00:48.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    A note shows recruitment is closed (no longer looking for participants). The record version has been updated to v3.6.0, replacing the prior v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T16:24:28.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Biocon Limited is listed as sponsor/collaborator in the study record, replacing Equillium. The record shows a new revision (v3.5.5) dated 2026-06-04, indicating an update to the sponsor/identification information.
    Difference
    0.8%
    Check dated 2026-06-05T11:47:15.000Z thumbnail image

Stay in the know with updates to Itolizumab in Lupus Nephritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Itolizumab in Lupus Nephritis Clinical Trial page.